Valosin-containing protein (VCP) is a highly expressed member of the type II AAA+ ATPase family. VCP mutations are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (IBMPFD) and they account for 1%-2% of familial amyotrophic lateral sclerosis (ALS). Using fibroblasts from patients carrying three independent pathogenic mutations in the VCP gene, we show that VCP deficiency causes profound mitochondrial uncoupling leading to decreased mitochondrial membrane potential and increased mitochondrial oxygen consumption. This mitochondrial uncoupling results in a significant reduction of cellular ATP production. Decreased ATP levels in VCP-deficient cells lower their energy capacity, making them more vulnerable to high energy-demanding processes such as ischemia. Our findings propose a mechanism by which pathogenic VCP mutations lead to cell death. Copyright © 2013 Elsevier Inc. All rights reserved.
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels / Bartolome, F; Wu, Hc; Burchell, Vs; Preza, E; Wray, S; Mahoney, Cj; Fox, Nc; Calvo, A; Canosa, A; Moglia, C; Mandrioli, J; Chiò, A; Orrell, Rw; Houlden, H; Hardy, J; Abramov, Ay; Plun-Favreau, H.. - In: NEURON. - ISSN 0896-6273. - 78:1(2013), pp. 57-64. [10.1016/j.neuron.2013.02.028]
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels
Mandrioli J;
2013
Abstract
Valosin-containing protein (VCP) is a highly expressed member of the type II AAA+ ATPase family. VCP mutations are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (IBMPFD) and they account for 1%-2% of familial amyotrophic lateral sclerosis (ALS). Using fibroblasts from patients carrying three independent pathogenic mutations in the VCP gene, we show that VCP deficiency causes profound mitochondrial uncoupling leading to decreased mitochondrial membrane potential and increased mitochondrial oxygen consumption. This mitochondrial uncoupling results in a significant reduction of cellular ATP production. Decreased ATP levels in VCP-deficient cells lower their energy capacity, making them more vulnerable to high energy-demanding processes such as ischemia. Our findings propose a mechanism by which pathogenic VCP mutations lead to cell death. Copyright © 2013 Elsevier Inc. All rights reserved.File | Dimensione | Formato | |
---|---|---|---|
PIIS0896627313001864.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
845.25 kB
Formato
Adobe PDF
|
845.25 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris